IBDEI0LQ ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10651,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10651,1,4,0)
 ;;=4^724.5
 ;;^UTILITY(U,$J,358.3,10651,1,5,0)
 ;;=5^Back Pain, Chronic
 ;;^UTILITY(U,$J,358.3,10651,2)
 ;;=^12250
 ;;^UTILITY(U,$J,358.3,10652,0)
 ;;=600.00^^67^682^13
 ;;^UTILITY(U,$J,358.3,10652,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10652,1,4,0)
 ;;=4^600.00
 ;;^UTILITY(U,$J,358.3,10652,1,5,0)
 ;;=5^BPH w/o Obstruction
 ;;^UTILITY(U,$J,358.3,10652,2)
 ;;=^334276
 ;;^UTILITY(U,$J,358.3,10653,0)
 ;;=490.^^67^682^16
 ;;^UTILITY(U,$J,358.3,10653,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10653,1,4,0)
 ;;=4^490.
 ;;^UTILITY(U,$J,358.3,10653,1,5,0)
 ;;=5^Bronchitis NOS
 ;;^UTILITY(U,$J,358.3,10653,2)
 ;;=^17164
 ;;^UTILITY(U,$J,358.3,10654,0)
 ;;=682.8^^67^682^19
 ;;^UTILITY(U,$J,358.3,10654,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10654,1,4,0)
 ;;=4^682.8
 ;;^UTILITY(U,$J,358.3,10654,1,5,0)
 ;;=5^Cellulitis NEC
 ;;^UTILITY(U,$J,358.3,10654,2)
 ;;=^271896
 ;;^UTILITY(U,$J,358.3,10655,0)
 ;;=585.9^^67^682^20
 ;;^UTILITY(U,$J,358.3,10655,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10655,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,10655,1,5,0)
 ;;=5^Chronic Renal Insufficiency
 ;;^UTILITY(U,$J,358.3,10655,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,10656,0)
 ;;=428.0^^67^682^17
 ;;^UTILITY(U,$J,358.3,10656,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10656,1,4,0)
 ;;=4^428.0
 ;;^UTILITY(U,$J,358.3,10656,1,5,0)
 ;;=5^CHF
 ;;^UTILITY(U,$J,358.3,10656,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,10657,0)
 ;;=496.^^67^682^18
 ;;^UTILITY(U,$J,358.3,10657,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10657,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,10657,1,5,0)
 ;;=5^COPD
 ;;^UTILITY(U,$J,358.3,10657,2)
 ;;=^24355
 ;;^UTILITY(U,$J,358.3,10658,0)
 ;;=414.01^^67^682^21
 ;;^UTILITY(U,$J,358.3,10658,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10658,1,4,0)
 ;;=4^414.01
 ;;^UTILITY(U,$J,358.3,10658,1,5,0)
 ;;=5^Coronary Artery Disease
 ;;^UTILITY(U,$J,358.3,10658,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,10659,0)
 ;;=311.^^67^682^22
 ;;^UTILITY(U,$J,358.3,10659,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10659,1,4,0)
 ;;=4^311.
 ;;^UTILITY(U,$J,358.3,10659,1,5,0)
 ;;=5^Depression
 ;;^UTILITY(U,$J,358.3,10659,2)
 ;;=^35603
 ;;^UTILITY(U,$J,358.3,10660,0)
 ;;=250.01^^67^682^23
 ;;^UTILITY(U,$J,358.3,10660,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10660,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,10660,1,5,0)
 ;;=5^Diabetes, Type 1
 ;;^UTILITY(U,$J,358.3,10660,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,10661,0)
 ;;=250.00^^67^682^24
 ;;^UTILITY(U,$J,358.3,10661,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10661,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,10661,1,5,0)
 ;;=5^Diabetes, Type 2
 ;;^UTILITY(U,$J,358.3,10661,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,10662,0)
 ;;=305.90^^67^682^26
 ;;^UTILITY(U,$J,358.3,10662,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10662,1,4,0)
 ;;=4^305.90
 ;;^UTILITY(U,$J,358.3,10662,1,5,0)
 ;;=5^Drug Abuse-Unspec
 ;;^UTILITY(U,$J,358.3,10662,2)
 ;;=^268258
 ;;^UTILITY(U,$J,358.3,10663,0)
 ;;=305.93^^67^682^25
 ;;^UTILITY(U,$J,358.3,10663,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10663,1,4,0)
 ;;=4^305.93
 ;;^UTILITY(U,$J,358.3,10663,1,5,0)
 ;;=5^Drug Abuse-In Remission
 ;;^UTILITY(U,$J,358.3,10663,2)
 ;;=^268261
 ;;^UTILITY(U,$J,358.3,10664,0)
 ;;=796.2^^67^682^28
 ;;^UTILITY(U,$J,358.3,10664,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10664,1,4,0)
 ;;=4^796.2
 ;;^UTILITY(U,$J,358.3,10664,1,5,0)
 ;;=5^Elevated BP w/o HTN
 ;;^UTILITY(U,$J,358.3,10664,2)
 ;;=^273464
 ;;^UTILITY(U,$J,358.3,10665,0)
 ;;=607.84^^67^682^29
